Cellergy Therapeutics

📍 Yavne, Israel🗓 Founded 2022👥 6 employees💰 Last funded Jul 2025
Biotechnology Research🌐 cellergy-bio.com
Website LinkedIn
🔬 Cellergy Therapeutics: Transforming Cellular Health Through Mitochondrial Innovation Our breakthrough approach harnesses the power of young, healthy mitochondria to revolutionize the treatment of degenerative and metabolic diseases. The Science Behind Our Innovation: Mitochondria - the cellular powerhouses - are essential for energy production, driving critical functions from muscle contraction to DNA repair. Yet with age, these vital organelles accumulate damage, leading to decreased cellular energy and contributing to various degenerative conditions. Our Solution: Through innovative mitochondrial transplantation therapy, we replace compromised mitochondria with fully functional ones, effectively restoring cellular energy production and enhancing cell function. Target Indications: Metabolic Disorders Type 2 Diabetes Neurodegenerative Diseases Age-related Conditions Join us as we advance this transformative technology to address critical unmet medical needs and enhance healthy longevity. #BiotechInnovation #CellularHealth #Mitochondria #DrugDevelopment #TherapeuticInnovation"
2
Total investors
0
Early stage
2
Mid stage
0
Late stage
2022
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Israel
2
Frequently asked questions
Who invested in Cellergy Therapeutics?
Cellergy Therapeutics has 2 investors on record on gritt.io, 2 mid-stage.
When did Cellergy Therapeutics last raise funding?
The most recent investment in Cellergy Therapeutics recorded on gritt.io was in July 2025.
When was Cellergy Therapeutics founded?
Cellergy Therapeutics was founded in 2022.
What industry is Cellergy Therapeutics in?
Cellergy Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Cellergy Therapeutics based?
Cellergy Therapeutics is headquartered in Yavne, Israel.